Institutional Venture Management Xiii LLC Decreased Holding in Care.Com INC (CRCM) by $28.80 Million

May 18, 2018 - By Donald McKee, Inc. (NYSE:CRCM) LogoInvestors sentiment increased to 3.74 in 2017 Q4. Its up 2.19, from 1.55 in 2017Q3. It increased, as 10 investors sold CRCM shares while 17 reduced holdings. 46 funds opened positions while 55 raised stakes. 38.36 million shares or 94.63% more from 19.71 million shares in 2017Q3 were reported. 69,889 were reported by Strs Ohio. Hutchin Hill Capital L P, New York-based fund reported 66,700 shares. Royal Bank Of Canada stated it has 0% in, Inc. (NYSE:CRCM). State Street has invested 0% in, Inc. (NYSE:CRCM). Blackrock reported 1.20 million shares. Rhumbline Advisers reported 12,808 shares. Teacher Retirement Systems Of Texas stated it has 196,739 shares. Amer Century Inc holds 0.01% or 355,922 shares in its portfolio. Hillsdale Inv Mngmt Incorporated reported 0.2% stake. Moreover, Geode Capital Mngmt Ltd has 0% invested in, Inc. (NYSE:CRCM) for 154,108 shares. First Quadrant Ltd Partnership Ca accumulated 3,364 shares or 0% of the stock. Natl Bank Of America De invested in 31,019 shares or 0% of the stock. Tiaa Cref Inv Mgmt Ltd Liability Corporation accumulated 201,484 shares. 58,581 were accumulated by Hsbc Public Ltd Liability Co. Aqr Cap Management Lc holds 0.01% in, Inc. (NYSE:CRCM) or 463,497 shares.

Since November 20, 2017, it had 0 insider buys, and 26 insider sales for $4.36 million activity. 6,519 shares were sold by Echenberg Michael, worth $119,470. 18,079 shares were sold by Marcelo Sheila Lirio, worth $321,338. Krupinski David had sold 10,000 shares worth $153,378 on Tuesday, May 1. 31,987 shares were sold by Miller J Sanford, worth $558,167 on Tuesday, December 12.

Institutional Venture Management Xiii Llc decreased its stake in Care.Com Inc. (CRCM) by 64.2% based on its latest 2017Q4 regulatory filing with the SEC. Institutional Venture Management Xiii Llc sold 1.60 million shares as the company’s stock declined 9.88% with the market. The institutional investor held 892,080 shares of the consumer services company at the end of 2017Q4, valued at $16.09M, down from 2.49M at the end of the previous reported quarter. Institutional Venture Management Xiii Llc who had been investing in Care.Com Inc. for a number of months, seems to be less bullish one the $574.98M market cap company. The stock increased 0.60% or $0.11 during the last trading session, reaching $18.58. About 132,024 shares traded., Inc. (NYSE:CRCM) has risen 41.48% since May 18, 2017 and is uptrending. It has outperformed by 29.93% the S&P500.

Analysts await, Inc. (NYSE:CRCM) to report earnings on August, 9. They expect $0.03 earnings per share, down 50.00 % or $0.03 from last year’s $0.06 per share. CRCM’s profit will be $928,392 for 154.83 P/E if the $0.03 EPS becomes a reality. After $0.08 actual earnings per share reported by, Inc. for the previous quarter, Wall Street now forecasts -62.50 % negative EPS growth.

More news for, Inc. (NYSE:CRCM) were recently published by:, which released: “ to Participate At Upcoming Investor Conferences” on May 09, 2018.‘s article titled: “Consolidated Research: 2018 Summary Expectations for Care, Unilever, CECO Environmental, Carter’s, ObsEva SA …” and published on May 14, 2018 is yet another important article., Inc. (NYSE:CRCM) Ratings Coverage

Among 2 analysts covering (NYSE:CRCM), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. had 3 analyst reports since February 28, 2018 according to SRatingsIntel. The firm has “Hold” rating by Stifel Nicolaus given on Wednesday, May 9. The company was maintained on Wednesday, February 28 by Stifel Nicolaus. Roth Capital maintained the shares of CRCM in report on Tuesday, February 27 with “Buy” rating., Inc. (NYSE:CRCM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: